Search results
Biden tells ally he is weighing whether to withdraw from 2024 race against Trump: Live updates
The Independent via Yahoo News· 11 minutes agoPresident struggling to soothe Democratic fears about his health as Republican rival continues to...
Netanyahu rejects report citing top Israeli generals as wanting a ceasefire in Gaza with Hamas still...
CNN via Yahoo News· 19 hours agoThe Israeli leader has rejected the idea of starting a ceasefire in Gaza while Hamas remains in...
A Powerful Investing Tool: Know a Stock's Relative Strength
Zacks via Yahoo News· 3 hours agoHowever, in Q4 2022, Super Micro...), a high-octane growth stock, printed fresh 52-week highs while ...
Capital gains tax: What is it and how could Labour use it to raise funds without driving rich tax...
Sky News via Yahoo News· 5 hours agoWhoever wins the next general election will face extremely tough choices on taxation and spending....
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Zacks via Yahoo News· 2 hours agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Chevron (CVX) Stock Barely Moves in a Month: An Opportunity?
Zacks via Yahoo News· 3 hours agoChevron's (CVX) robust financial performance in Q1, with $5.5 billion in earnings and a free cash...
LAUSD shelves its hyped AI chatbot to help students after collapse of firm that made it
LA Times via Yahoo News· 5 hours agoLAUSD sidelines "Ed," an AI chatbot, after a splashy kick-off featuring a company that has now...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo News· 3 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be ...
Robinhood (HOOD) Buys Pluto Capital, Eyes Wealth Business
Zacks via Yahoo News· 3 hours agoRobinhood (HOOD) acquires Pluto Capital. The move will significantly enhance its investment platform...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo News· 3 hours agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...